The Sanger Mouse Genetics Programme: high throughput characterisation of knockout mice
about
Substitution p.A350V in Na⁺/Mg²⁺ exchanger SLC41A1, potentially associated with Parkinson's disease, is a gain-of-function mutationZNF367 inhibits cancer progression and is targeted by miR-195Association of fatty-acid synthase polymorphisms and expression with outcomes after radical prostatectomy.Cilia gene mutations cause atrioventricular septal defects by multiple mechanisms.
P2860
The Sanger Mouse Genetics Programme: high throughput characterisation of knockout mice
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The Sanger Mouse Genetics Programme: high throughput characterisation of knockout mice
@ast
The Sanger Mouse Genetics Programme: high throughput characterisation of knockout mice
@en
The Sanger Mouse Genetics Programme: high throughput characterisation of knockout mice
@en-gb
type
label
The Sanger Mouse Genetics Programme: high throughput characterisation of knockout mice
@ast
The Sanger Mouse Genetics Programme: high throughput characterisation of knockout mice
@en
The Sanger Mouse Genetics Programme: high throughput characterisation of knockout mice
@en-gb
prefLabel
The Sanger Mouse Genetics Programme: high throughput characterisation of knockout mice
@ast
The Sanger Mouse Genetics Programme: high throughput characterisation of knockout mice
@en
The Sanger Mouse Genetics Programme: high throughput characterisation of knockout mice
@en-gb
P921
P1433
P1476
The Sanger Mouse Genetics Programme: high throughput characterisation of knockout mice
@en
P2093
P356
10.1111/J.1755-3768.2010.4142.X
P577
2010-09-01T00:00:00Z